Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06153953
Other study ID # Soh-Med-23-11-01MS
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date December 2023
Est. completion date May 2024

Study information

Verified date November 2023
Source Sohag University
Contact Mohsen A ahmed attaelkareem, resident
Phone 01063846084
Email mohsenatta@med.sohag.edu.eg
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Diabetes is a global epidemic and a leading cause of death by disease. An estimated 366 million people worldwide had diabetes in 2011.(1).The incidence of diabetic foot ulcers (DFUs) and diabetic complications increases as the age increases.(2).Up to 25% of patients with diabetes will suffer from a foot ulcer during their lifetime. Ulceration is a pivotal factor in the causal pathway to infection and amputation.(3,4).Diabetic foot ulcers (DFUs) are the main cause of hospitalization in diabetic patients and they are considered a worldwide health problem. In recent years, the improvement in diabetes therapy and the reinforcement of guidelines have reduced the amputation rate.(5).The etiology of DFU is complex and rarely unifactorial. In general, foot ulcers are the cumulative result of repetitive trauma that wears a hole in the skin. The triad of neuropathy, foot deformity, and minor considers as the major contributing factors of ulcer development.(6).Vacuum therapy or Negative Pressure Wound Therapy is a technology uses a piece of foam in contact with the wound bed, covered by an occlusive dressing and placed under sub atmospheric pressure.(7).In other words NPWT is a non-invasive therapy system that uses controlled negative pressure using a vacuum device to promote wound healing by removing fluid from open wounds through a sealed dressing or a foam dressing connected to a collection container using sub-atmospheric pressure.(8).The system produces granular tissue that has a characteristic rough appearance. The device can decrease the depth and area of large diabetic foot wounds into a shallow, smaller wound.(8,9).NPWT was first proposed by Argenta and Morykwas in 1997. From then it has been approved as an effective modality of dressing in chronic wounds.(1).NPWT is a safe modality of dressing it has shown a few complications. Minor complications encountered in the vacuum-treated patients : erosion of adjacent tissue due to increased local pressure underneath the tubing ,mild reactions of the peri-wound area (i.e. maceration and eczema) , and sudden increase in body temperature.(10)


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 100
Est. completion date May 2024
Est. primary completion date May 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 15 Years to 70 Years
Eligibility Inclusion Criteria: - Adult patients with diabetic non ischemic wounds which match the criteria suitable for the procedure. Exclusion Criteria: - • Patients with chronic limb ischemia non-palpable distal pulsation. - Lack of good hemostasis in the wound. - Patients with malignant ulcers. - Hepatic patients and patients receiving radio or chemotherapy. - Wounds over untreated osteomyelitis. - Wounds with fistulae to organs or body cavities. - Presence of necrotic tissue. - Exposed arteries/nerves/anastomotic site/organ

Study Design


Related Conditions & MeSH terms


Intervention

Device:
vacuum device
use of vacuum device in dressing of diabetic wounds
Other:
conventional dressing therapy
us of conventional dressing with betadine and iruxol in diabetic wounds

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Sohag University

References & Publications (4)

Apelqvist J, Armstrong DG, Lavery LA, Boulton AJ. Resource utilization and economic costs of care based on a randomized trial of vacuum-assisted closure therapy in the treatment of diabetic foot wounds. Am J Surg. 2008 Jun;195(6):782-8. doi: 10.1016/j.amjsurg.2007.06.023. Epub 2008 Mar 26. — View Citation

Armstrong DG, Lavery LA; Diabetic Foot Study Consortium. Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomised controlled trial. Lancet. 2005 Nov 12;366(9498):1704-10. doi: 10.1016/S0140-6736(05)67695-7. — View Citation

Armstrong DG, Marston WA, Reyzelman AM, Kirsner RS. Comparative effectiveness of mechanically and electrically powered negative pressure wound therapy devices: a multicenter randomized controlled trial. Wound Repair Regen. 2012 May-Jun;20(3):332-41. doi: 10.1111/j.1524-475X.2012.00780.x. — View Citation

Blume PA, Walters J, Payne W, Ayala J, Lantis J. Comparison of negative pressure wound therapy using vacuum-assisted closure with advanced moist wound therapy in the treatment of diabetic foot ulcers: a multicenter randomized controlled trial. Diabetes Care. 2008 Apr;31(4):631-6. doi: 10.2337/dc07-2196. Epub 2007 Dec 27. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary duration of healing healing progress 6 months
See also
  Status Clinical Trial Phase
Recruiting NCT04591691 - C-myc Biomarker Study for Diabetic Foot Ulcers
Recruiting NCT06004219 - Peer Support for Patients With Diabetic Foot Ulcers N/A
Completed NCT04405765 - Cryopreserved vs. Lyopreserved Stravix as an Adjunct to NPWT in the Treatment of Complex Wounds Phase 4
Withdrawn NCT04405050 - RCT to Compare Restrata and NPWT to Heal Complex DFUs Phase 4
Completed NCT04558775 - TEWL Biomarker Study for Diabetic Foot Ulcer Recurrence
Completed NCT05191758 - Nutritional Regulation of Leukocyte Function N/A
Recruiting NCT04315909 - The Effect of Platelet-Rich Plasma-Fibrin Glue in Combination With Vitamin E and C for Treatment of Non-healing Diabetic Foot Ulcers Phase 2/Phase 3
Recruiting NCT05850611 - The Effect of Combination Therapy of Oral MB and PRP-FG in Patients With Non-healing Diabetic Foot Ulcer Early Phase 1